Targeting the NLRP3 inflammasome to treat cardiovascular fibrosis
AA Pinar, TE Scott, BM Huuskes, FET Caceres… - Pharmacology & …, 2020 - Elsevier
… to cardiovascular pathophysiology and fibrosis progression, … inflammation, the above-mentioned
pro-fibrotic factors and myofibroblasts remain activated, contributing to adverse tissue …
pro-fibrotic factors and myofibroblasts remain activated, contributing to adverse tissue …
From systemic inflammation to myocardial fibrosis: the heart failure with preserved ejection fraction paradigm revisited
WJ Paulus, MR Zile - Circulation research, 2021 - Am Heart Assoc
… The present review will therefore first focus on pathophysiological mechanisms linking
systemic inflammation to myocardial stiffness. It will subsequently address inflammatory/fibrotic …
systemic inflammation to myocardial stiffness. It will subsequently address inflammatory/fibrotic …
Idiopathic pulmonary fibrosis: an update on pathogenesis
Q Mei, Z Liu, H Zuo, Z Yang, J Qu - Frontiers in pharmacology, 2022 - frontiersin.org
… Idiopathic pulmonary fibrosis (IPF) is a progressive, lethal fibrotic … Although the exact
pathophysiological mechanisms underlying … The inflammatory and fibrotic mediators and immune …
pathophysiological mechanisms underlying … The inflammatory and fibrotic mediators and immune …
Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease–novel insights into cellular communication circuits
… in metabolic and inflammatory insults. On the other hand, storage of fat in adipose tissue or
liver … liver histology, underlining the complex pathophysiology of these conditions. Specific …
liver … liver histology, underlining the complex pathophysiology of these conditions. Specific …
Oncostatin M and its role in fibrosis
L Stawski, M Trojanowska - Connective tissue research, 2019 - Taylor & Francis
… stages of the fibrotic process including inflammation, vascular … tissue injury results in
excessive and uncontrolled ECM deposition (Citation1). Pathophysiological stages of fibrosis …
excessive and uncontrolled ECM deposition (Citation1). Pathophysiological stages of fibrosis …
Myofibroblasts: function, formation, and scope of molecular therapies for skin fibrosis
Y Tai, EL Woods, J Dally, D Kong, R Steadman… - Biomolecules, 2021 - mdpi.com
… in pathophysiological processes. Myofibroblasts mediate wound contractions, but their
persistent presence in tissues is central to driving fibrosis, … into inflammation-induced fibrosis has …
persistent presence in tissues is central to driving fibrosis, … into inflammation-induced fibrosis has …
When things go wrong: exploring possible mechanisms driving the progressive fibrosis phenotype in interstitial lung diseases
… and development of fibrosis in two inflammatory ILDs, ie … IPF, a typical progressive fibrosis
with limited inflammation. We then … many challenges since the pathophysiology and even the …
with limited inflammation. We then … many challenges since the pathophysiology and even the …
The epithelial-to-mesenchymal transition as a possible therapeutic target in fibrotic disorders
J Di Gregorio, I Robuffo, S Spalletta… - Frontiers in cell and …, 2020 - frontiersin.org
… basis of the pathophysiological mechanisms of EMT, their regulation, and the roles played by
EMT in fibrotic … and inflammatory cells in the fibrotic tissue. In fact, in various models of liver …
EMT in fibrotic … and inflammatory cells in the fibrotic tissue. In fact, in various models of liver …
Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets
K Sriram, PA Insel - Physiological reviews, 2021 - journals.physiology.org
… These ECM proteins are produced in increased amounts in lung fibrosis (88) and endothelial
inflammation (89), which are features of the ANG II-mediated COVID-19 pathobiology (…
inflammation (89), which are features of the ANG II-mediated COVID-19 pathobiology (…
Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis
… The histopathological hallmarks include subpleural fibrosis, … The recent introduction of two
anti-fibrotic drugs, pirfenidone … that the exact pathophysiological mechanisms involved in IPF …
anti-fibrotic drugs, pirfenidone … that the exact pathophysiological mechanisms involved in IPF …